Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-02-25 @ 8:25 PM
Study NCT ID:
NCT00087204
Status:
COMPLETED
Last Update Posted:
2013-01-23
First Post:
2004-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | View |
| None | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | View |
| None | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | View |
| None | Blastic Phase Chronic Myelogenous Leukemia | View |
| None | Chronic Myelomonocytic Leukemia | View |
| None | de Novo Myelodysplastic Syndromes | View |
| None | Previously Treated Myelodysplastic Syndromes | View |
| None | Recurrent Adult Acute Lymphoblastic Leukemia | View |
| None | Recurrent Adult Acute Myeloid Leukemia | View |
| None | Refractory Anemia With Excess Blasts | View |
| None | Refractory Anemia With Excess Blasts in Transformation | View |
| None | Relapsing Chronic Myelogenous Leukemia | View |
| None | Secondary Acute Myeloid Leukemia | View |
| None | Secondary Myelodysplastic Syndromes | View |
Keywords: